Cargando…
Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial
INTRODUCTION: Portal vein thrombosis (PVT) increases the risk of variceal rebleeding in liver cirrhosis. However, the strategy for preventing variceal rebleeding in cirrhotic patients with PVT has not been explored. This study aims to evaluate whether the transjugular intrahepatic portosystemic shun...
Autores principales: | Qi, Xingshun, He, Chuangye, Yin, Zhanxin, Wang, Zhengyu, Zhang, Hongbo, Yao, Liping, Wang, Jianhong, Xia, Jielai, Cai, Hongwei, Yang, Zhiping, Bai, Ming, Guo, Wengang, Niu, Jing, Wu, Kaichun, Fan, Daiming, Han, Guohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710980/ https://www.ncbi.nlm.nih.gov/pubmed/23847271 http://dx.doi.org/10.1136/bmjopen-2013-003370 |
Ejemplares similares
-
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: A hypothesis
por: Qi, Xingshun, et al.
Publicado: (2012) -
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan
por: Tsuruya, Kota, et al.
Publicado: (2023) -
Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes
por: Helzberg, James H, et al.
Publicado: (2022) -
Using transjugular intrahepatic portosystemic shunt as the first‐line therapy in secondary prophylaxis of variceal hemorrhage
por: Liu, Jiacheng, et al.
Publicado: (2019) -
Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites in Gaucher Disease
por: Adhyaru, Kunal, et al.
Publicado: (2022)